These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2516412)

  • 1. The molecular, biochemical and human pharmacology of thromboxane A2 in renal disease.
    FitzGerald GA; Murray R; Price P; Catella F
    Adv Exp Med Biol; 1989; 259():325-60. PubMed ID: 2516412
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboxane biosynthesis and metabolism in cardiovascular and renal disease.
    Patrono C; Patrignani P; Daví G
    J Lipid Mediat; 1993; 6(1-3):411-5. PubMed ID: 8357999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
    Iida N
    Nihon Rinsho; 1991 Dec; 49 Suppl():746-52. PubMed ID: 1839689
    [No Abstract]   [Full Text] [Related]  

  • 4. Revisiting the usefulness of thromboxane-A2 modulation in the treatment of bronchoconstriction in asthma.
    Hernandez JM; Janssen LJ
    Can J Physiol Pharmacol; 2015 Feb; 93(2):111-7. PubMed ID: 25581104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney.
    Rubin SI
    J Am Vet Med Assoc; 1986 May; 188(9):1065-8. PubMed ID: 3086264
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Moncada S; Vane JR
    Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
    Smith EF
    Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A2, released by the anti-tumour drug irinotecan, is a novel stimulator of Cl- secretion in isolated rat colon.
    Sakai H; Sato T; Hamada N; Yasue M; Ikari A; Kakinoki B; Takeguchi N
    J Physiol; 1997 Nov; 505 ( Pt 1)(Pt 1):133-44. PubMed ID: 9409477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of renal arachidonate metabolism in chronic glomerular disease.
    Patrono C; Ciabattoni G; Simonetti BM; Pierucci A
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():199-204. PubMed ID: 2949549
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of renal inflammatory cell infiltrate with thromboxane.
    Lim LK; Alijani MR; Helfrich GB; Foegh ML
    Transplant Proc; 1988 Apr; 20(2):258-9. PubMed ID: 3284053
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.
    Nakahata N
    Pharmacol Ther; 2008 Apr; 118(1):18-35. PubMed ID: 18374420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.
    Kushiku K; Ohjimi H; Yamada H; Kuwahara T; Furukawa T
    J Pharmacol Exp Ther; 1995 Jan; 272(1):70-6. PubMed ID: 7815366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin resistance.
    Violi F; Pignatelli P
    Lancet; 2006 Jun; 367(9528):2059-60. PubMed ID: 16798385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular pharmacology and application to the bronchial asthma of thromboxane A2 antagonists].
    Kohno S
    Nihon Rinsho; 1996 Feb; 54(2):551-8. PubMed ID: 8838113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens reduce thromboxane production by cultured human endothelial cells.
    Oviedo PJ; Sobrino A; Novella S; Rius C; Laguna-Fernandez A; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
    Climacteric; 2011 Feb; 14(1):41-8. PubMed ID: 20443717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of thromboxane A2 receptor antagonists.
    Halushka PV
    Z Kardiol; 1989; 78 Suppl 3():42-7. PubMed ID: 2530712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.